Skip to Main content Skip to Navigation

Rôle des Pioneer Translation Products (PTPs) dans la réponse immunitaire anti-tumorale.

Abstract : Anti-tumoral therapeutic vaccines rely on the activation of the adaptative immune system and are based on the recognition of tumor antigens (TA) by specific helper and cytotoxic T lymphocytes (CTL). Their efficacy requires a careful selection of the targeted antigens as well as an unaltered MHC class I (MHC-I) antigenic presentation in tumors. While the focus was first put on exome-derived TA, evidences highlighted the ones derived from alternative translations as having a high potential as T-cells targets. These can be derived from translation of allegedly non coding sequences, initiated at alternative codons or performed in non-canonical open reading frames. Such an alternative translation occurring from pre-spliced mRNAs in the nucleus has been described as giving rise to the Pioneer Translation Products (PTPs), which constitute a source of polypeptides for the MHC-I pathway. Recently, we showed that PTPs-derived antigens presented by tumors are able to elicit a CTL response in vivo that controls tumor growth. Here, we identified one positive modulator of PTPs-derived antigenic presentation in cancer cells: the splicing inhibitor isoginkgetin. Then, we provided one of its derivatives, the IP2, which is water soluble and less toxic than the isoginkgetin, and showed that IP2 treatment increases PTPs-derived antigenic presentation of cancer cells in vitro and reduces tumor growth in vivo in an immune-dependent manner. Hence we describe here the IP2 as a new efficient immunomodulator of the antitumor response, promising for the development of innovative therapeutic strategies.
Document type :
Complete list of metadatas

Cited literature [401 references]  Display  Hide  Download
Contributor : Abes Star :  Contact
Submitted on : Thursday, January 2, 2020 - 1:38:43 AM
Last modification on : Wednesday, October 14, 2020 - 3:41:52 AM


Version validated by the jury (STAR)


  • HAL Id : tel-02426237, version 1



Alison Pierson. Rôle des Pioneer Translation Products (PTPs) dans la réponse immunitaire anti-tumorale.. Biologie cellulaire. Université Paris Saclay (COmUE), 2017. Français. ⟨NNT : 2017SACLS446⟩. ⟨tel-02426237⟩



Record views


Files downloads